CASE ANALYSIS:
Toby is a 41-year-old patient who has cryptogenic partial epilepsy. He experienced his first seizure at age 14 and this was diagnosed as a secondary generalised attack, although discussing his history revealed he might have had complex partial seizures. Two years ago Toby was referred for assessment but it was felt that he was not a candidate for surgery. Toby was taking carbamazepine 1200mg a day and could not tolerate higher doses. Previous trials of valproate, phenytoin, phenobarbital, vigabatrin, lamotrigine, oxcarbazepine and topiramate had demonstrated little benefit. Levetiracetam was started and increased to 2500mg. Improvement in seizure control has been noted over the past 2 years with only two nocturnal complex partial seizures recorded. His current medication is levetiracetam 2500mg/day and carbamazepine 1200mg/day.
DRUG THERAPY MANAGEMENT:
|
GENERIC NAME |
BRAND NAME |
DOSAGE/ FORM |
FREQUENCY |
INDICATION FOR THE PATIENT |
MONITORING PARAMETERS |
|
|
|
|
|
|
|
SUBJECTIVE |
OBJECTIVE |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
ADVERSE DRUG REACTION:
DRUG INTERACTIONS:
RECOMMENDATIONS:
Step by step
Solved in 2 steps
